Latest Financial Updates

Read latest financial news update from our blog

What to expect from consumer, power companies in coming quarters? Amnish Aggarwal answers
What to expect from consumer, power companies in coming quarters? Amnish Aggarwal answers

Live Events You Might Also Like: Amnish Aggarwal on Torrent Pharma plan to acquire JB Che...

Admin | Finance | 1 week ago

Picsart: AI-Powered Photo and Video Editor
Picsart: AI-Powered Photo and Video Editor

• 13 reviews Older restaurants like Junoon arePicsart CUSTOMER SERVICE +1 (8O5)-3O1 7O71...

Admin | Finance | 1 week ago

For 85% of Enterprise CFOs, Agentic AI Remains a Question Mark
For 85% of Enterprise CFOs, Agentic AI Remains a Question Mark

Investment and Trust Barriers: A slowdown in overall GenAI investment, coupled with the ev...

Admin | Finance | 1 week ago

WorkWhile Reinvents Hourly Work With AI-Powered Labor Platform
WorkWhile Reinvents Hourly Work With AI-Powered Labor Platform

Watch more: How Marqeta Found Work For Taylor Swift’s Eras Tour Staff By completing this...

Admin | Finance | 1 week ago

Subtle Clue Suggests AirPods Pro 3 Are Closer Than Ever to Launch!
Subtle Clue Suggests AirPods Pro 3 Are Closer Than Ever to Launch!

A recent discovery has added fuel to the speculation surrounding the AirPods Pro 3, as a n...

Admin | Finance | 1 week ago

Dory - App Switcher: An app switcher for people who can’t remember shortcuts
Dory - App Switcher: An app switcher for people who can’t remember shortcuts

Dory is an app switcher for people who can’t remember shortcuts. Just click your middle mo...

Admin | Finance | 1 week ago

Optimism in Trade Talks Boosts Korean Won to Highest Level Since October
Optimism in Trade Talks Boosts Korean Won to Highest Level Since October

The South Korean won has seen its value rise against the U.S. dollar, reaching its highest...

Admin | Finance | 1 week ago

Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London | HNSA Stock News
Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London | HNSA Stock News

Hansa Biopharma (HNSA, Financial) reveals positive five-year outcomes for imlifidase in ki...

Admin | Finance | 1 week ago

Join Our Newsletter

join our newsletter to receive update from us